HLA-B*35-restricted CD8 T cell epitopes in the antigen 85 complex of Mycobacterium tuberculosis

被引:30
作者
Klein, MR
Smith, SM
Hammond, AS
Ogg, GS
King, AS
Vekemans, J
Jaye, A
Lukey, PT
McAdam, KPWJ
机构
[1] MRC Labs, TB Res Programme, Fajara, Gambia
[2] London Sch Hyg & Trop Med, Dept Infect & Trop Dis, Immunol Unit, London WC1, England
[3] Inst Mol Med, MRC, Human Immunol Unit, Oxford, England
[4] GlaxoSmithKline Res & Dev Ltd, Resp Syst, Stevenage, Herts, England
基金
英国医学研究理事会;
关键词
D O I
10.1086/319267
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Few target epitopes have been described for human CD8 T lymphocytes in antigens of Mycobacterium tuberculosis. By use of a reverse immunogenetics approach, 23 motif-bearing peptides of the Ag85 complex were tested for binding to HLA-B*35, one of the common B-types in West Africa. Three 9-mer peptides bound with high affinity to HLA-B*3501 and displayed low dissociation rates of peptide-major histocompatibility complexes (MHCs). IC50 and half-life values of peptide-MHC class I complexes were in the same range as reported earlier for other immunogenic peptides. Immune responses against peptide Ag85C (aa 204-212) WPTLIGLAM were characterized in detail. Peptide-stimulated effector cells were able to kill macrophages infected with M. tuberculosis or bacille Calmette-Guerin. Peptide-specific CD8 T cells could be visualized by using HLA-B*3501 tetramers and were shown to produce interferon-gamma and tumor necrosis factor-alpha. Together with other published epitopes, these peptides can be used to study more closely the role of CD8 T cells in mycobacterial infection and tuberculosis.
引用
收藏
页码:928 / 934
页数:7
相关论文
共 45 条
[21]   T-cell epitope mapping by flow cytometry [J].
Kern, F ;
Surel, IP ;
Brock, C ;
Freistedt, B ;
Radtke, H ;
Scheffold, A ;
Blasczyk, R ;
Reinke, P ;
Schneider-Mergener, J ;
Radbruch, A ;
Walden, P ;
Volk, HD .
NATURE MEDICINE, 1998, 4 (08) :975-978
[22]  
Klein Michel R., 1999, Archivum Immunologiae et Therapiae Experimentalis, V47, P313
[23]  
KORBER BTM, 2000, HIV MOL IMMUNOLOGY D
[24]   IMMUNE-RESPONSE TO MYCOBACTERIUM-BOVIS BACILLE CALMETTE-GUERIN INFECTION IN MAJOR HISTOCOMPATIBILITY COMPLEX CLASS I-DEFICIENT AND II-DEFICIENT KNOCK-OUT MICE - CONTRIBUTION OF CD4 AND CD8 T-CELLS TO ACQUIRED-RESISTANCE [J].
LADEL, CH ;
DAUGELAT, S ;
KAUFMANN, SHE .
EUROPEAN JOURNAL OF IMMUNOLOGY, 1995, 25 (02) :377-384
[25]   Optimization of a peptide-based protocol employing IL-7 for in vitro restimulation of human cytotoxic T lymphocyte precursors [J].
Lalvani, A ;
Dong, T ;
Ogg, G ;
Pathan, AA ;
Newell, H ;
Hill, AVS ;
McMichael, AJ ;
Rowland-Jones, S .
JOURNAL OF IMMUNOLOGICAL METHODS, 1997, 210 (01) :65-77
[26]   Human cytolytic and interferon γ-secreting CD8+ T lymphocytes specific for Mycobacterium tuberculosis [J].
Lalvani, T ;
Brookes, R ;
Wilkinson, RJ ;
Malin, AS ;
Pathan, AA ;
Andersen, P ;
Dockrell, H ;
Pasvol, G ;
Hill, AVS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (01) :270-275
[27]   Characterization of human CD8+ T cells reactive with Mycobacterium tuberculosis-infected antigen-presenting cells [J].
Lewinsohn, DM ;
Alderson, MR ;
Briden, AL ;
Riddell, SR ;
Reed, SG ;
Grabstein, KH .
JOURNAL OF EXPERIMENTAL MEDICINE, 1998, 187 (10) :1633-1640
[28]   Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA [J].
Ogg, GS ;
Jin, X ;
Bonhoeffer, S ;
Dunbar, PR ;
Nowak, MA ;
Monard, S ;
Segal, JP ;
Cao, YZ ;
Rowland-Jones, SL ;
Cerundolo, V ;
Hurley, A ;
Markowitz, M ;
Ho, DD ;
Nixon, DF ;
McMichael, AJ .
SCIENCE, 1998, 279 (5359) :2103-2106
[29]   PRECISE PREDICTION OF A DOMINANT CLASS-I MHC-RESTRICTED EPITOPE OF LISTERIA-MONOCYTOGENES [J].
PAMER, EG ;
HARTY, JT ;
BEVAN, MJ .
NATURE, 1991, 353 (6347) :852-855
[30]  
PARKER KC, 1994, J IMMUNOL, V152, P163